Expression of latent membrane proteins in Epstein‑Barr virus-transformed lymphocytes in vitro

Tang,Yunlian; Luo,Chunyan; Cheng,Ailan; Lu,Suli; Xu,Jinhua; Fu,Ting; Gan,Runliang

doi:10.3892/mmr.2014.2313

August-2014 Volume 10 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2014 Volume 10 Issue 2

Full Size Image

Article

Expression of latent membrane proteins in Epstein‑Barr virus-transformed lymphocytes in vitro

Authors:
- Yunlian Tang
- Chunyan Luo
- Ailan Cheng
- Suli Lu
- Jinhua Xu
- Ting Fu
- Runliang Gan
View Affiliations / Copyright

Affiliations: Cancer Research Institute, University of South China, Hengyang, Hunan 421001, P.R. China
Pages: 1117-1121
|
Published online on: June 10, 2014

https://doi.org/10.3892/mmr.2014.2313
Expand metrics +

Abstract

Infection with Epstein-Barr virus (EBV) induces activation and proliferation of B lymphocytes. Detection of latent membrane protein (LMP)-1 is used to identify the proliferative ability of B cells. However, changes in the expression levels of the three LMPs during EBV-induced B lymphocyte transformation, have not yet been reported. In the present study, the expression levels of LMP-1, LMP-2A and LMP-2B were compared between EBV-transformed B lymphocytes and paired normal lymphocytes. Seven lymphoblast cell lines were established by EBV infection of normal human lymphocytes in vitro. The expression levels of LMP genes and LMP-1 protein were determined using quantitative (q)PCR and western blotting in lymphoblasts and normal lymphocytes, respectively. The expression of LMP1, LMP-2A and LMP-2B genes was significantly upregulated in EBV-induced lymphoblasts compared with the normal lymphocytes. The LMP-1 protein level was also significantly increased in EBV-transformed B lymphocytes. Expression of LMP1, LMP-2A and LMP-2B genes was significantly upregulated in EBV-induced lymphoblasts, suggesting LMP genes are important in the transformation of human lymphocytes.

View Figures

View References

1	Lan K, Verma SC, Murakami M, Bajaj B and Robertson ES: Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage. Curr Protoc Microbiol. Chapter 14(Unit 14E): 122007.PubMed/NCBI
2	Michelow P, Wright C and Pantanowitz L: A review of the cytomorphology of Epstein-Barr virus-associated malignancies. Acta Cytol. 56:1–14. 2012. View Article : Google Scholar : PubMed/NCBI
3	Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G and Klein E: Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. J Immunol Methods. 385:60–70. 2012. View Article : Google Scholar : PubMed/NCBI
4	Klein E, Kis LL and Klein G: Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions. Oncogene. 26:1297–1305. 2007. View Article : Google Scholar : PubMed/NCBI
5	Pang MF, Lin KW and Peh SC: The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Cell Mol Biol Lett. 14:222–247. 2009.PubMed/NCBI
6	Kanegane H, Yachie A, Miyawaki T and Tosato G: EBV-NK cells interactions and lymphoproliferative disorders. Leuk Lymphoma. 29:491–498. 1998. View Article : Google Scholar : PubMed/NCBI
7	Tomita M, Dewan MZ, Yamamoto N, Kikuchi A and Mori N: Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes. Cancer Sci. 100:807–812. 2009. View Article : Google Scholar : PubMed/NCBI
8	Lee CW, Leu SJ, Tzeng RY, et al: Latent membrane protein 1 of Epstein-Barr virus regulates death-associated protein kinase 1 in lymphoblastoid cell line. Virology. 413:19–25. 2011. View Article : Google Scholar : PubMed/NCBI
9	Rechsteiner MP, Berger C, Zauner L, et al: Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. J Virol. 82:1739–1747. 2008. View Article : Google Scholar : PubMed/NCBI
10	Shair KH, Bendt KM, Edwards RH, Nielsen JN, Moore DT and Raab-Traub N: Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model. J Virol. 86:5352–5365. 2012. View Article : Google Scholar
11	Bultema R, Longnecker R and Swanson-Mungerson M: Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis. Oncogene. 28:1471–1476. 2009. View Article : Google Scholar : PubMed/NCBI
12	Zhang B, Kracker S, Yasuda T, et al: Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell. 148:739–751. 2012. View Article : Google Scholar : PubMed/NCBI
13	Dellis O, Arbabian A, Papp B, Rowe M, Joab I and Chomienne C: Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells. J Biol Chem. 286:18583–18592. 2011. View Article : Google Scholar
14	Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP and Ling PD: Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 6:e272712011. View Article : Google Scholar : PubMed/NCBI
15	Yoshizaki T: A novel immune evasion mechanism of LMP-1, an EBV-primary oncogene, in nasopharyngeal carcinoma. Adv Otorhinolaryngol. 72:157–159. 2011.PubMed/NCBI
16	Wang LT, Lin CS, Chai CY, Liu KY, Chen JY and Hsu SH: Functional interaction of Ugene and EBV infection mediates tumorigenic effects. Oncogene. 30:2921–2932. 2011. View Article : Google Scholar : PubMed/NCBI
17	Yu H, Lu J, Zuo L, et al: Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells. J Virol. 86:3088–3099. 2012. View Article : Google Scholar
18	Guasparri I, Bubman D and Cesarman E: EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood. 111:3813–3820. 2008. View Article : Google Scholar : PubMed/NCBI
19	Vrazo AC, Chauchard M, Raab-Traub N and Longnecker R: Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice. PLoS Pathog. 8:e10026622012. View Article : Google Scholar : PubMed/NCBI
20	Fotheringham JA, Mazzucca S and Raab-Traub N: Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation. Oncogene. 29:4287–4296. 2010. View Article : Google Scholar : PubMed/NCBI
21	Rechsteiner MP, Bernasconi M, Berger C and Nadal D: Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency. Trends Microbiol. 16:520–527. 2008. View Article : Google Scholar : PubMed/NCBI